Brief: GlobeImmune announces updates
17/11/2016 22:49
Nov 17 (Reuters) - GlobeImmune Inc GBIM.PK
* GlobeImmune announces updates
* GlobeImmune Inc says Gilead Sciences Inc has terminated
collaboration and license agreement with company
* GlobeImmune Inc says Timothy C. Rodell has resigned his
positions as company's chief executive officer and president but
remains on board of directors
* GlobeImmune Inc says rights to GS-4774 have been returned
to GlobeImmune
Source text for Eikon: urn:newsml:reuters.com:*:nMKWZf1tPa
Further company coverage: GBIM.PK
((bangalore.newsroom@thomsonreuters.com;))
Recent news on GlobeImmune
See all newsBrief: GlobeImmune announces updates
Brief: Globeimmune to delist and deregister common stock from Nasdaq Capital Market
Brief: GlobeImmune reports Q1 loss per share of $0.15
Brief: GlobeImmune hires Cantor Fitzgerald to assist in review of strategic alternatives
Brief: GlobeImmune says net income of $0.9 million for three months ended September 30, 2015